RxDoctor Payments Data

Tom Lassar

Cardiovascular Disease · Cleveland, OHNPI 1487670048

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $15,300 of the $21,215 with a category attached, or 72.1%. Chiesi USA, Inc. accounts for 78.7% of it on its own, with 23 other manufacturers making up the rest. Reporting peaked in 2020 at $10,435 and has fallen 97.6% since, to $247 in 2024.

$21,215in general payments, 2019–2025

Across 84 payments — averaging $252.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Chiesi USA, Inc.$17K
  • Janssen Scientific Affairs, LLC$2K
  • Abiomed$285
  • AstraZeneca$252
  • Pfizer$248
  • Abbott$201
  • plus $2K from 18 others

What the payments were for

  • Consulting fees$2,0009%
  • Speaking & faculty fees$15,30072%
  • Travel & lodging$8544%
  • Food & beverage$2,97714%
  • Education$80%
  • Gifts$750%

General payments by program year

19
20
21
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$21,215 in reported general payments places this provider in the 85th percentile of 827 cardiovascular disease providers in Ohio.

See all cardiovascular disease providers in Ohio →

Other cardiovascular disease in Cleveland

See the full list for Ohio →

Where these figures come from

Is this you, or does something look wrong? →